We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




3D Imaging Rapidly Diagnoses Aggressive Prostate Cancer

By HospiMedica International staff writers
Posted on 04 Jan 2022
Deep-learning (DL) can enable tissue microstructures to be volumetrically segmented to improve prediction of aggressive prostate cancer, according to a new study. More...


The new technique, called image-translation-assisted segmentation in 3D (ITAS3D), developed at the University of Washington (UW; Seattle, USA), and Case Western Reserve University (CWRU; Cleveland, OH, USA), enables annotation-free, biomarker-based interpretation of glandular features, without requiring immunolabeling. Instead, it implements non-destructive 3D pathology and computational analysis of whole prostate biopsies, which are labeled with a rapid, inexpensive fluorescent analog of standard hematoxylin and eosin staining.

The computational 3D approach was applied to 300 biopsies extracted from 50 archived radical prostatectomy specimens, of which 118 contained cancer. The results showed that 3D features in the prostate cancer biopsies were superior to 2D features for risk stratification, and provided more information on the complex tree-like structure of the glands, thus increasing the likelihood that the computer would correctly predict a cancer's aggressiveness. The study was published on December 1, 2021, in Cancer Research.

“The 3D glandular features in cancer biopsies were superior to corresponding 2D features for risk stratification of low- to intermediate-risk prostate cancer patients based on their clinical biochemical recurrence outcomes,” concluded lead author Weisi Xie, PhD, of UW, and colleagues. “An end-to-end pipeline for DL-assisted computational 3D histology analysis of whole prostate biopsies shows that nondestructive 3D pathology has the potential to enable superior prognostic stratification of prostate cancer patients.”

The microscopic structure of the prostate gland is the basis for prognostic grading by pathologists; however, prostate cancer treatment planning is largely dependent upon examination of core-needle biopsies. Since the interpretation of the convoluted 3D glandular structure via visual inspection of a limited number of 2D histology sections is often unreliable, both under- and over-treatment of such patients is common.

Related Links:
University of Washington
Case Western Reserve University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.